Immunovant, Inc. (IMVT)
26.69
-1.06
(-3.82%)
USD |
NASDAQ |
Mar 03, 11:31
Immunovant Price : 26.69 for March 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Boston Scientific Corp. | 73.50 |
| Viridian Therapeutics, Inc. | 29.04 |
| Plus Therapeutics, Inc. | 0.2785 |
| Nutriband, Inc. | 4.10 |
| Definium Therapeutics, Inc. | 17.29 |
Price Related Metrics
| PEG Ratio | -3.932 |
| Price to Book Value | 5.509 |
| Earnings Yield | -10.05% |
| Market Cap | 5.432B |
| PEGY Ratio | -3.932 |